Company Filing History:
Years Active: 2012-2023
Title: The Innovative Contributions of Philippe Wolgen
Introduction
Philippe Wolgen is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of medicine, particularly in the treatment of vitiligo. With a total of three patents to his name, Wolgen's work reflects a commitment to advancing therapeutic options for patients.
Latest Patents
Wolgen's latest patents focus on a therapy for vitiligo. The present invention relates to a pharmaceutical composition comprising an alpha melanocyte stimulating hormone (alpha-MSH) analogue. This composition can be used either alone or in combination with narrow band UVB and/or one or more corticosteroids, immunosuppressants, anti-inflammatory agents, and/or photochemotherapeutic agents for the treatment or prevention of vitiligo.
Career Highlights
Throughout his career, Philippe Wolgen has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Clinuvel Pharmaceuticals Limited and Vallaurix Mc S.a.r.l. His experience in these organizations has contributed to his expertise in developing innovative therapies.
Collaborations
Wolgen has collaborated with esteemed professionals in his field, including Thomas A. Luger and Karin Loser. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Philippe Wolgen's contributions to the field of medicine, particularly in the treatment of vitiligo, showcase his dedication to innovation. His patents and collaborations reflect a significant impact on therapeutic advancements.